Back to Results
First PageMeta Content
Antipruritics / Amines / Mepyramine / Pyridines / Topical / Lidocaine / Pharmaceutical drug / Pharmacy / Pseudoephedrine / Medicine / Pharmacology / Chemistry


Submissions to the Medicines Classification Committee for the Reclassification of
Add to Reading List

Document Date: 2014-05-20 20:50:21


Open Document

File Size: 101,69 KB

Share Result on Facebook

City

Wellington / /

Company

Sanofi-Aventis New Zealand Limited / Pharmaceutical Solutions Ltd / Terri Kong Regulatory Associate Pharmaceutical Solutions Ltd / /

Country

United States / Canada / Australia / United Kingdom / New Zealand / /

/

Event

FDA Phase / Product Issues / /

Facility

Pharmacy Medicine / Northern Steamship Building / Pharmacy Regulatory Authorities / CMC Building / Pharmacy Only / /

IndustryTerm

reference product / /

MedicalCondition

insomnia / eczema / itchiness / itching / pain / cut / allergic reactions / infection / inflammation / rash / nettle rash / /

Organization

National Association of Pharmacy Regulatory Authorities / Centre for Adverse Reactions Monitoring / MHRA / New Zealand Retailers Association / Therapeutic Goods Administration / Medicines Classification Committee for the Reclassification of TOPICAL MEPYRAMINE MALEATE / NZ Retailers Association / /

/

Position

Governor / pharmacist / Executive / General / /

Product

lidocaine / Anthisan Topical cream / Lidocaine hydrochloride / skin surfaces / Anthisan / topical / ANTHISAN Cream / C17H23N3O / /

Technology

http / /

URL

http /

SocialTag